Insulet Corporation Gross Profit | PODD

Gross profit is a key indicator of how efficiently a company produces or sells its products. This metric helps assess a business’s ability to generate revenue at the initial stage, before accounting for all other expenses. Regular analysis of gross profit allows companies to respond in a timely manner to changes in cost of goods, pricing strategy, and market conditions.

Calculation formula:
Gross Profit = Revenue – Cost of Goods Sold (COGS)

Revenue — all cash inflows from the sale of goods or services.
Cost of Goods Sold — direct costs related to the production or acquisition of goods:

Raw materials and supplies

Wages of production personnel

Depreciation of equipment

Transportation and warehousing costs (if directly related to production)

Importance for business:

Assessing core business profitability
If gross profit is declining, it may indicate rising production costs or falling sales.
Financial planning
Gross profit is the basis for calculating other key metrics, such as operating and net profit.
Benchmarking against competitors
Gross profit analysis helps compare the efficiency of different companies within the same industry.
Insights into pricing effectiveness
If gross profit is low, the company may be pricing too low or failing to control costs effectively.

Reasons for a decline in gross profit:

Increase in raw material and supply costs
Rising production expenses
Price reductions due to competition
Decrease in sales volume
Currency exchange rate fluctuations (for imports/exports)

Gross profit is an important metric, but it does not provide a complete picture of a company’s financial health, as it does not account for administrative and selling expenses, taxes, debt burden, or depreciation.

Annual Gross Profit Insulet Corporation

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008
1.94 B	1.45 B	1.16 B	806 M	752 M	582 M	480 M	110 M	277 M	211 M	148 M	143 M	112 M	92.3 M	66.7 M	43.7 M	18.3 M	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.94 B	18.3 M	493 M

Quarterly Gross Profit Insulet Corporation

2026-Q2	2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
563 M	529 M	510 M	452 M	409 M	-	377 M	331 M	307 M	-	293 M	265 M	240 M	-	188 M	190 M	210 M	-	189 M	183 M	168 M	-	152 M	142 M	127 M	134 M	123 M	116 M	107 M	110 M	102 M	82.1 M	75.8 M	79.5 M	73.6 M	64.6 M	59.4 M	60.9 M	55.6 M	50.5 M	44.1 M	42 M	31.6 M	30.5 M	29.2 M	33.1 M	33.7 M	31.8 M	28.4 M	33 M	27.4 M	26.8 M	25.2 M	25.3 M	24.4 M	22.3 M	20.3 M	20.1 M	18.6 M	14.5 M	13.5 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
563 M	13.5 M	137 M

Gross Profit of other stocks in the Medical devices industry

Issuer	Gross Profit	Price	% 24h	Market Cap	Country
Conformis CFMS	23.2 M	-	-	$ 16.4 M	USA
Bruker Corporation BRKR	1.58 B	$ 64.0	7.26 %	$ 9.72 B	USA
Boston Scientific Corporation BSX	13.9 B	$ 44.68	0.06 %	$ 66.1 B	USA
Cognyte Software Ltd. CGNT	290 M	$ 8.7	0.06 %	$ 634 M	Israel
ClearPoint Neuro CLPT	22.7 M	$ 14.61	13.03 %	$ 414 M	USA
CONMED Corporation CNMD	750 M	$ 45.18	3.31 %	$ 1.4 B	USA
Cytosorbents Corporation CTSO	26.5 M	$ 4.3	1.63 %	$ 268 M	USA
Eargo EAR	14.3 M	-	-	$ 10.2 M	USA
Delcath Systems DCTH	73.4 M	$ 16.08	0.75 %	$ 576 M	USA
Medigus Ltd. MDGS	6.68 M	-	10.28 %	$ 55.5 M	Israel
Cutera CUTR	-12.7 M	-	-10.19 %	$ 1.99 M	USA
Electromed ELMD	57.9 M	$ 27.86	1.05 %	$ 230 M	USA
Establishment Labs Holdings ESTA	146 M	$ 65.58	3.69 %	$ 1.94 B	Costa-rica
Edwards Lifesciences Corporation EW	4.73 B	$ 85.73	0.32 %	$ 50.1 B	USA
Nemaura Medical NMRD	-1.48 M	-	-17.8 %	$ 2.74 M	Britain
AdaptHealth Corp. AHCO	89.3 M	$ 5.57	0.43 %	$ 753 M	USA
Helius Medical Technologies HSDT	5.52 M	$ 2.9	0.69 %	$ 63.9 M	USA
Integra LifeSciences Holdings Corporation IART	953 M	$ 15.88	2.25 %	$ 1.22 B	USA
Inogen INGN	154 M	$ 5.23	2.75 %	$ 139 M	USA
InMode Ltd. INMD	291 M	$ 14.19	0.21 %	$ 917 M	Israel
Inspire Medical Systems INSP	779 M	$ 68.81	0.59 %	$ 2.02 B	USA
Neovasc NVCN	1.99 M	-	-	$ 111 M	Canada
IRIDEX Corporation IRIX	19.2 M	$ 0.63	2.51 %	$ 10.7 M	USA
IRadimed Corporation IRMD	64.3 M	$ 85.2	0.08 %	$ 1.08 B	USA
AxoGen AXGN	167 M	$ 43.32	0.48 %	$ 1.99 B	USA
Align Technology ALGN	2.71 B	$ 145.63	4.36 %	$ 10.6 B	USA
LENSAR LNSR	14.1 M	$ 7.08	0.28 %	$ 84.7 M	USA
Sientra SIEN	3.23 M	-	-16.59 %	$ 10.3 M	USA
Silk Road Medical, Inc SILK	127 M	-	-	$ 1.07 B	USA
Medtronic PLC MDT	19.6 B	$ 88.51	0.32 %	$ 113 B	USA
MiMedx Group MDXG	346 M	$ 4.71	0.1 %	$ 696 M	USA
Surgalign Holdings SRGA	40.3 M	-	-32.98 %	$ 1.68 M	USA
ShockWave Medical SWAV	635 M	-	-	$ 12.3 B	USA
Myomo MYO	26.9 M	$ 1.67	1.83 %	$ 69.9 M	USA
Nano-X Imaging Ltd. NNOX	-12.8 M	$ 0.66	0.45 %	$ 42.8 M	Israel
InspireMD NSPR	2.65 M	$ 0.7	0.37 %	$ 45 M	Israel
Orthofix Medical OFIX	566 M	$ 9.16	0.11 %	$ 363 M	Curacao
Outset Medical OM	46.8 M	$ 3.13	1.29 %	$ 47.6 K	USA
Profound Medical Corp. PROF	11.4 M	$ 5.6	1.66 %	$ 169 M	Canada
Quanterix Corporation QTRX	65 M	$ 3.18	0.63 %	$ 136 M	USA
Natus Medical Incorporated NTUS	274 M	-	1.94 %	$ 1.05 B	USA
AVITA Medical RCEL	58.8 M	$ 11.58	5.75 %	$ 323 M	Australia
Cardiovascular Systems CSII	173 M	-	0.15 %	$ 844 M	USA
Apyx Medical Corporation APYX	33 M	$ 2.83	1.37 %	$ 116 M	USA
Sintx Technologies SINT	461 K	$ 1.87	5.06 %	$ 5.19 M	USA
Accuray Incorporated ARAY	111 M	$ 0.22	0.4 %	$ 27 M	USA
Smith & Nephew plc SNN	4.19 B	$ 26.68	0.02 %	$ 23.1 B	Britain
Inari Medical NARI	435 M	-	-	$ 4.23 B	USA